Related Experiment Videos
What is seronegative rheumatoid arthritis?
Scandinavian Journal of Rheumatology. Supplement
|January 1, 1988
Summary
Diagnosing seronegative rheumatoid arthritis (RA) is challenging due to its overlap with other inflammatory arthropathies. This study presents criteria to improve the definition and diagnosis of rheumatoid factor seronegative RA.
Area of Science:
- Rheumatology
- Immunogenetics
Background:
- Distinguishing seronegative polyarthritides from rheumatoid arthritis (RA) and ankylosing spondylitis (AS) presents diagnostic challenges.
- Seronegative RA, defined by the absence of rheumatoid factor (RF), requires precise diagnostic criteria to differentiate it from other arthritic conditions.
- Previous studies on HLA antigens, specifically HLA-DR4, and their association with RA have been complicated by difficulties in defining seronegative RA patients.
Purpose of the Study:
- To address the diagnostic difficulties in classifying seronegative polyarthritides.
- To establish clear criteria for identifying patients with rheumatoid factor seronegative RA.
- To clarify the association between HLA-DR4 and RA by improving the definition of seronegative RA.
Main Methods:
- Review of existing literature and clinical data on seronegative polyarthritides.
- Analysis of patient cohorts with suspected RA and other inflammatory arthropathies.
- Development and presentation of a set of diagnostic criteria for RF seronegative RA.
Main Results:
- The study highlights the complexities in diagnosing seronegative RA, particularly excluding other seronegative arthritides.
- Difficulties in confirming seronegativity for rheumatoid factors and establishing an RA diagnosis are noted.
- Conflicting opinions regarding the association between RF and HLA-DR4 in RA patients are attributed to diagnostic ambiguities.
Conclusions:
- Clear diagnostic criteria are essential for accurately defining and classifying seronegative RA.
- Improved diagnostic criteria can help resolve inconsistencies in research findings, such as the HLA-DR4 association.
- The proposed criteria aim to enhance the accurate identification of patients with rheumatoid factor seronegative RA.